Celestin de Wergifosse
Co-founder and CEO of Signature Biosciences, a spin-out focused on making precision diagnostics more accessible by converting centralized gene-expression tests into easy-to-run qPCR kits for hospital labs.
Best podcasts with Celestin de Wergifosse
Ranked by the Snipd community
Mar 1, 2026 • 49min
Can precision diagnostics be made more accessible?
Celestin de Wergifosse, CEO of Signature Biosciences, builds PCR kits to bring gene-expression tests into hospital labs. Christoph Ruedig, Albion VC partner and former physician, invests in early-stage healthtech. They discuss making precision diagnostics run on existing lab equipment, tackling cost and scaling bottlenecks, integrating tests into clinical workflows, and the sensible roles and risks of AI and wearables.
